Kelly is a pharmacist with a master’s degree in medicines regulatory affairs who joined EMA following several years working in the pharmaceutical industry, primarily in pharmacovigilance. At EMA, Kelly has contributed to the implementation of the 2012 European Union pharmacovigilance legislation and has extensive experience in signal management and real-world evidence. She currently coordinates the EMA–Heads of Medicines Agencies Patient Registries Initiative. Her expertise also includes international regulatory collaboration on real-world evidence, including work with the International Coalition of Medicines Regulatory Authorities and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
To invite:
Senior EMA Representative